Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
involved, the assays, and the clinical and possible pathogenic consequences.
Blood 81: 1996-2002.
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch,
JV, Steinman, RM and Nussenzweig, MC (2001). Dendritic cells induce
peripheral T cell unresponsiveness under steady state conditions in vivo. J.
Exp. Med. 194(6): 769-779.
Hitt, M., Bett, AJ, Addison, CL, Prevec, L. und Graham, FL (1995). Techniques
for human adenovirus vector construction and characterization. Adolph, KW
(Hrsg.) Viral Gene Techniques Vol. 7, Academic Press, San Diego: 13-30.
Huber, S., Schramm, C., Lehr, HA, Mann, A., Schmitt, S., Becker, C., Protschka,
M., Galle, PR, Neurath, MF and Blessing, M. (2004). Cutting edge: TGF-β
signaling is required for the in vivo expansion and immunosuppressive
capacity of regulatory CD4+CD25+ T cells. J. Immunol. 173: 6526-6531.
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. and
Levitsky, H. (1998). The central role of CD4(+) T cells in the antitumor immune
response. J. Exp. Med. 188(12): 2357-2368.
Ikeguchi, M. and Kaibara, N. (2001). Changes in survivin messenger RNA level
during cisplatin treatment in gastric cancer. Int. J. Mol. Med. 8: 661-666.
Islam, A., Kageyama, H., Hashizume, K., Kaneko, Y. and Nakagawara, A
(2000). Role of survivin, whose gene is mapped to 17q25, in human
neuroblastoma and identification of a novel dominant-negative isoform,
survivin-beta/2B. Med. Pediatr. Oncol. 35: 550-553.
Jaeger, E., Bernhard, H., Romero, P., Ringhoffer, M., Arand, M., Karbach, J.,
Ilsemann, C., Hagedorn, M. and Knuth, A. (1996). Generation of cytotoxic T-
106